These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1976651)

  • 1. High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes.
    Ottaway CA; Lay TE; Greenberg GR
    J Neuroimmunol; 1990; 29(1-3):149-55. PubMed ID: 1976651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide.
    Roberts AI; Panja A; Brolin RE; Ebert EC
    Dig Dis Sci; 1991 Mar; 36(3):341-6. PubMed ID: 1847328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion and internalization of vasoactive intestinal peptide (VIP) receptors in murine CD4 T lymphocytes.
    Ottaway CA
    Regul Pept; 1992 Sep; 41(1):49-59. PubMed ID: 1360688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased binding of HIV-1 and vasoactive intestinal peptide following plasma membrane fluidization of CD4+ cells by phenytoin.
    Lehr HA; Zimmer JP; Hübner C; Ballmann M; Hachmann W; Vogel W; Baisch H; Hartter P; Albani M; Kohlschütter A
    Virology; 1990 Dec; 179(2):609-17. PubMed ID: 1978437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine mucosal T cells have VIP receptors functionally distinct from those on intestinal epithelial cells.
    Blum AM; Mathew R; Cook GA; Metwali A; Felman R; Weinstock JV
    J Neuroimmunol; 1992 Jul; 39(1-2):101-8. PubMed ID: 1320055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes.
    Peuriere S; Susini C; Esteve JP; Vaysse N; Escoula L
    Regul Pept; 1990 Jan; 27(1):117-26. PubMed ID: 2155441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.
    O'Dorisio MS; Shannon BT; Fleshman DJ; Campolito LB
    J Immunol; 1989 May; 142(10):3533-6. PubMed ID: 2541199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line.
    Nielsen FC; Gammeltoft S; Westermark B; Fahrenkrug J
    Peptides; 1990; 11(6):1225-31. PubMed ID: 1965033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of vasoactive intestinal peptide (VIP) with human peripheral blood lymphocytes: specific binding and cyclic AMP production.
    Calvo JR; Guerrero JM; Molinero P; Blasco R; Goberna R
    Gen Pharmacol; 1986; 17(2):185-9. PubMed ID: 3009267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice.
    Voice JK; Grinninger C; Kong Y; Bangale Y; Paul S; Goetzl EJ
    J Immunol; 2003 Jan; 170(1):308-14. PubMed ID: 12496414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sulfhydryl groups in the binding of vasoactive intestinal peptide to its receptor on murine lymphocytes.
    Ottaway CA
    J Neuroimmunol; 1992 Jul; 39(1-2):49-56. PubMed ID: 1320058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vasoactive intestinal peptide receptors in retina.
    Swedlund AP; Rosenzweig SA
    Exp Eye Res; 1990 Sep; 51(3):317-23. PubMed ID: 2169429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
    Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
    J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulomas in murine schistosomiasis mansoni contain vasoactive intestinal peptide-responsive lymphocytes.
    Weinstock JV; Blum AM; Khetarpal S
    Cell Immunol; 1991 May; 134(2):458-72. PubMed ID: 1673641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.
    Gozes Y; Brenneman DE; Fridkin M; Asofsky R; Gozes I
    Brain Res; 1991 Feb; 540(1-2):319-21. PubMed ID: 1647246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
    Elgavish A; Pillion DJ; Meezan E
    Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J; Martin JM; el Battari A; Reynier M; Marvaldi J; Pichon J
    Eur J Biochem; 1989 Mar; 180(2):429-33. PubMed ID: 2538330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly.
    Ottaway CA
    J Neuroimmunol; 1992 Jun; 38(3):241-53. PubMed ID: 1318321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.